PCN136 Cost-Effectiveness Analysis of Dacomitinib Versus Gefitinib for the First-line Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR)-Activating Mutations in Portugal
Keyword(s):
Keyword(s):
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7012-7012
◽
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7012-7012
◽
Keyword(s):
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7537-7537
◽
Keyword(s):